Background: Few data exist regarding the incidence of vascular complications associated with transfemoral catheterization and sheath placement into synthetic vascular grafts.
(p=0.007). All cases had blood loss anemia and at least two of the above clinical features. Mean hospital stay was longer in RPH cases (2.2±1.3 vs. 1.7±1.5 days, p=0.06). The use of GP IIb/IIIa inhibitors and the method of vascular closure had no effect on the risk of RPH. There was also no association between RPH and acuity of PCI (elective vs. emergent), duration of procedure, heparin dose, ACT level, arterial sheath size, insertion of a venous sheath, or prior femoral artery puncture. Female sex was most strongly associated with RPH (OR 5.0, 95% CI 1.7-14.5). Angiographic analysis revealed that a higher femoral artery puncture in relation to the femoral head (superior third of the femoral head and higher vs. mid third and lower) was also associated with RPH (OR 4.2, 95% CI 1. , p=0.09). The wall thickness of normal, non-infarcted myocardium increased significantly more in controls than in treated animals. ERPs of the MSC group were significantly shorter than controls at all pacing cycle lengths in LV peri-infarct, LV free wall (FW), and right ventricular (RV) FW (225+6, 227+5, 225+6 ms, vs 251+6, 251+6, 247+7 ms, all p<=0.002). The mean slope of the ERP restitution curves was steeper in the MSC group than in controls (1.6±0.8 vs 1.0±0.4, p=0.02). DiI was identified in the lungs and myocardium of treated animals. Conclusions: IV infusion of MSCs soon after reperfused acute MI in swine improves LV function, lessens compensatory hypertrophy of non-infarcted myocardium, shortens ERP, and steepens the ERP restitution curve. Clinical trials assessing the efficacy of IV MSC therapy after MI in humans should include arrhythmia monitoring.
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Comparison Background: Experimental data suggest that mesencymal stem cell (MSC) therapy contributes to healing after acute myocardial infarction(AMI). The ideal route of administration is still contrversial. Methods: A total of 10 dogs were divided in three groups:a)Control n=3; b)Intracoronary (IC) n=3 and c) NOGA guided transendocardial injections (TEI) n=4. All animals had an anterior wall AMI induced by ligation of LAD artery for three hours and then reperfused. The animals received cell therapy (100 million MSC's(Osiris)) 1 wk after AMI and were sacrificed 2 wks after cell therapy. 2D-echo was performed immediately before AMI, cell therapy and sacrifice. NOGA mapping was performed immediately before cell therapy and sacrifice. Ischemic area was measured by NOGA. ANOVA was performed.
Results: The 2D-echo findings concerning ejection fraction (EF), end-diastolic dimension (EDD), end-systolic dimension (ESD), and ischemic area are presented in table 1. The TEI group had a statistically significant increase in EF (p=0.006), a reduction in EDD(p=0.04), a reduction in ESD (p=0.02), and more importantly a reduction in ischemic area (p=0.006) when compared to the control group. All the other comparisons did not reach statistical significance (p>0.05).
